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Table S1. Statistics of the PCA model generated after 2 FFD cycle (out of 590 variables, 346 
were retained). 
Component SSX SSXacc VarX VarXacc 
1 44.76 44.76 40.98 40.98 
2 14.77 59.53 12.61 53.60 
3 10.94 70.48 9.88 63.48 
4 6.00 76.47 4.94 68.42 
5 4.62 81.09 3.84 72.26 
 
 
 
Table S2. Statistics of 3LV PLS model applying different CV procedures.  Settings: FFD-LV = 3, 
20% of dummy variables, 20 randomization cycles, 4 random groups. 2 cycles of FFD were 
applied. 
Component SSXacc SDEC SDEP r
2
acc q
2
acc 
3 LV (LOO) 60.69 2.19 4.55 0.92 0.67 
3LV (LTO) 59.76 2.26 4.83 0.92 0.62 
3 LV (RG) 61.48 2.37 5.36 0.91 0.54 
 
 
 
Table S3. Statistics of the PCA model generated after 2 FFD cycle (out of 600 variables, 316 
were retained). 
Component SSX SSXacc VarX VarXacc 
1 44.93 44.93 41.78 41.78 
2 12.94 57.87 10.98 52.76 
3 9.04 66.92 7.75 60.51 
4 6.87 73.78 6.06 66.57 
5 4.51 78.30 3.72 70.30 
 
 
 
Table S4. Statistics of 2LV PLS model applying different CV procedures.  Settings: FFD-LV = 3, 
20% of dummy variables, 20 randomization cycles, 4 random groups. 2 cycles of FFD were 
applied. 
Component SSXacc SDEC SDEP r
2
acc q
2
acc 
2LV (LOO) 54.51 3.09 4.51 0.81 0.59 
2LV (LTO) 54.27 3.19 4.78 0.79 0.54 
2LV (RG) 54.28 3.15 4.82 0.80 0.53 
 
 
 
 Experimental Section 
 
Materials 
Salicylaldehyde, methyl-2-pyridyl ketone, methyl-3-pyridyl ketone, methyl 4-pyridyl ketone, 2-
pyridinecarboxaldehyde, 3-pyridinecarboxaldehyde, 4-pyridinecarboxaldehyde, 2-
quinolinecarboxaldehyde, 6-methyl-2-pyridinecarboxaldehyde and thiocarbohydrazide were 
obtained from Sigma. 8-quinolinecarboxaldehyde (98 %) and 8-hydroxy-2-
quinolinecarboxaldehyde (98 %) were obtained from Acros Organics. All used solvents were of 
spectroscopic quality.  
 
Methods 
Elemental analyses (C, H, N) were performed by the standard micromethods using the 
ELEMENTARVario ELIII C.H.N.S=O analyzer. Fourier-transform infrared (FTIR) spectra were 
obtained using FTIR BOMEM MB 100 in the form of KBr pellets. FTIR spectra were recorded in 
the transmission mode between 400 and 4000 cm–1 with a resolution of 4 cm–1. Abbreviations 
used for IR spectra: vs, very strong; s, strong; m, medium; w, weak. All NMR spectral 
measurements were performed on a Bruker Avance III 500 spectrometer equipped with a 
broad-band direct probe. The spectra were recorded at room temperature in DMSO-d6. 
Chemical shifts are given on δ scale relative to tetramethylsilane (TMS), as internal standard for 
1H and 13C. Coupling constants (J) were expressed in Hz. Abbreviations used for NMR spectra: 
s, singlet; dd, doublet of doublets; ddd,  double double doublet.   
 
General procedure for synthesis of m-TCHs 1-11 
A mixture of thiocarbohydrazide (dhS, 1 mmol) and various N-heteroaromatic aldehydes and 
ketone (0.5 mmol) was refluxed for about 3 h in 30 mL mixture of ethanol/water (1:3, v/v) with a 
one drop of hydrochloric acid. After completion of the reaction, the crude product was filtered 
and recrystallized from appropriate solvent to obtained pure compound. The compounds 1 [1], 2 
and 5 [2], 7 [3], 8-10 [4],  and 11 [5], are known compounds which have been previously 
synthesized. All these components are synthesized according to our procedures and their purity 
was verified through melting point and elemental analysis. Synthesis for compound 6 has been 
published before [6], but without spectral characterization. Here, we presented detailed 
characterization of 6. 
Methyl 3-pyridyl ketone thiocarbonohydrazone (3). Yellow crystal; Yield 88 %;  M.p. 174-175 oC; 
IR (KBr, cm-1) vmax:  3273s (NH2), 3169m (NH), 3018w (CHaryl), 1507vs (amide II), 1224s (C=S); 
1H NMR (500 MHz, DMSO-d6, δ ppm):  2,30 (s, 3H, H-C8); 4,96 (s, 2H, H–N5); ); 7,39 (dd, 1H,  
H–C5, 3J5,4 = 8,0 Hz, 
3J5,6 = 4,8 Hz); 8,36 (dd, 1H, H–C4, 
3J4,5 =8,0 Hz); 8,55 (dd, 1H, H–C6, 
3J6,5 = 4,8 Hz,); 9,13 (d, 1H, H–C2 ); 9,90 (s, 1H, H-N4); 10,31 (s, 1H, H–N3); 
13C NMR (126 
MHz, DMSO-d6, δ ppm, TMS): 13,61 (C8); 123,15 (C5); 133,20 (C3); 133,90 (C4); 145,60 (C7); 
147,89 (C2); 149,65 (C6); 176,20 (C9); Elemental Analysis:  Calculated:: %C, 45.91; %H, 5.30; 
%N, 33.47; %S, 15,32 %, Found: %C, 45.88; %H, 5.20; %N, 33.35; %S, 15,44 %. Solvent for 
crystallization: methanol (Figs. S1-S2). 
 
Methyl 4-pyridyl ketone thiocarbonohydrazone (4). Yellow solid; Yield 74 %;  M.p. 201-202oC; IR 
(KBr, cm-1) vmax:  3297s (NH2), 3167m (NH), 3024w (CHaryl), 1501vs (amide II), 1220s (C=S); 
1H 
NMR (500 MHz, DMSO-d6, δ ppm):  δ: 2,27 (s, 3H, H-C8); 4,98 (s, 2H, H–N5); 7,93 (d,d 2H,  H–
C3, H–C5, 3J3,2 = 
3J5,6 = 4,7 Hz); 8,57 (d,d 2H, H–C2 = H–C6, 
3J2,3 = 
3J6,5 = 4,7 Hz); 9,97 (s, 1H, 
H–N4); 10,40 (s, 1H, H–N3); 13C NMR (126 MHz, DMSO-d6, δ ppm, TMS): 13,24 (C8); 120,72 
(C3,C5); 144,70 (C7); 145,09 (C4); 149,72 (C2,C6); 176,19 (C9); Elemental Analysis:  
Calculated: %C, 45.91; %H, 5.30; %N, 33.47, %S, 15,32 %, Found: %C, 45.95; %H, 5.22; %N, 
33.28, %S, 15,36.  Solvent for crystallization: ethanol (Figs. S3-S4). 
 
3-pyridylaldehyde thiocarbohydrazones (6) Yelow solid; Yield 74 %; M.p. 200-201 oC. IR (KBr, 
cm-1) vmax:  3263s (NH2), 3164m (NH), 2961w (CHaryl), 1503vs (amide II), 1272s (C=S); 
1H NMR 
(500 MHz, DMSO-d6, δ ppm): 4,90 (s, 2H, H-N5 ); 7,41 (dd, 1H,  H–C5, 
3J5,4 = 7,9 Hz, 
3J5,6 = 
4,75 Hz); 8,02 (s, 1H, H-C7); 8,30 (d, 1H, H–C4, 3J4,5 =7,9 Hz); 8,54 (dd, 1H, H–C6, 
3J6,5 = 
4,75); 8,93 (d, 1H, H–C2); 9,97 (s, 1H, H–N4); 11,57 (s, 1H, H–N3). 13C NMR (126 MHz, 
DMSO-d6, δ ppm, TMS):  123,69 (C5); 130,28 (C3); 133,86 (C4); 139,05 (C7); 148,83 (C2); 
150,15 (C6); 175,85 (C8); Elemental Analysis:  Calculated: %C, 43.06; %H, 4.65; %N, 35.87; 
%S, 16.42. Found:  %C, 42.98; %H, 4.61; %N, 35.72 %; %S, 16.33. Solvent for crystallization: 
ethanol (Figs. S5-S6). 
 
General procedure for synthesis of b-TCHs 12-22 
Solution of N-heteroaromatic aldehydes and ketone (2,1 mmol) in ethanol (10 mL) was added 
into hot solution of dhS (1 mmol) in ethanol (40 mL). After the catalytic amount of conc. 
hydrochloric acid was added, reaction mixture was stirred and refluxed for 3 h at 80 C. The 
resulting precipitate was collected by filtration and recrystallized from appropriate solvent. The 
syntheses of compounds  12 [7, 8], 13, 14,[10] 15-18 [8], 19-21 [4], and 22 [9] have been published 
earlier. All these components are synthesized according to our procedures and their purity was 
verified through melting point and elemental analysis.   
 
Antimicrobial activity  
Agar diffusion method 
Antibacterial activity was evaluated using four different strains of Gram-positive bacteria: 
Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538), Clostridium sporogenes 
(ATCC 19404) and Kocuria rhizophila (ATCC 9341), and four different strains of Gram-negative 
bacteria: Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 9027), Proteus 
hauseri (ATCC 13315) and Salmonella enterica subsp. enterica serovar Enteritidis (ATCC 
13076). Antibacterial activity was determined by the well diffusion method. [11]  To each Petri 
dish (90 mm diameter), 22 mL of nutrient agar (HiMedia, Mumbai, India) and 100 μL of bacterial 
suspension (106 colony forming units (CFU)) were added. A well with a diameter of 8 mm was 
then punched carefully using a sterile cork borer and 100 μL test substance (1 mg/100 μL 
DMSO) were added to each labeled well. Amikacin (30 μg/100 μL H2O) was used as a positive 
control, whereas 100 μL water and DMSO served as negative controls. The same procedure 
was repeated for different microorganisms. After the inoculation of the organisms, compounds 
and controls, the plates were incubated for 24 h at 37 °C. Zones of bacterial growth inhibition 
were recorded in millimeters.  The fungi tested were: Candida albicans (ATCC 10231), 
Saccharomyces cerevisiae (ATCC 9763) and Aspergillus brasiliensis (ATCC 16404). 
Sabouraud dextrose agar (Torlak, Belgrade, Serbia) was prepared according to the 
manufacturer's instructions. Into each sterile Petri dish (90 mm diameter), 22 mL of agar 
suspension was poured and 100 μL of fungi suspension (105 CFU) were added. A wells with a 
diameter of 8 mm were punched in agar using a sterile cork borer. Into each well 100 μL of test 
substance (1 mg/100 μL DMSO) were added. Nystatin (30 μg/100 μL DMSO) was used as a 
positive control, whereas 100 μL of DMSO served as a negative control. The plates were 
incubated for 48 h at 24 °C. Antifungal activity was determined by measuring the diameter of the 
inhibition zone. 
 
Broth microdilution antimicrobial assay 
Minimum inhibitory (MIC) and bactericidal concentrations (MBC) of the compounds  were 
determined using broth microdilution method according to CLSI 2005 [12,13]. Antimicrobial activity 
was tested against two bacterial and one fungal strain of the American Type Culture Collection 
(ATCC): Staphylococcus aureus 6538, Pseudomonas aeruginosa 9027, and C. albicans 10231.  
The antimicrobial assay was performed in 96-well microtiter plates (Sarstedt, Gerrmany). 
Mueller Hinton broth was used for bacterial strains and malt broth for candida (BioLife, Milan, 
Italy). The concentration of microbial suspensions was set to 105 CFU. The compounds were 
dissolved in 5% DMSO aqueous solution, covering the range of concentrations from 0.0024 to 5 
mg/mL. Triphenyltetrazolium chloride (TTC, 0.0075%) was added to bacterial suspension as a 
growth indicator.  Positive growth control was 5% DMSO in appropriate medium. Bacterial 
strains were incubated for 24 h at 37 °C, while candida was incubated for 48 h at 25 °C. The 
concentration of compound at which there was no visible microbial growth was taken as a MIC 
value. MBC was determined by serial sub-cultivation of the samples taken from each well that 
showed no visible microbial growth into microtiter plates containing appropriate medium. The 
lowest concentration of each compound that achieved the loss of any visible growth after 
repeated incubation was considered as MBC. All determinations were performed in triplicate. 
 
Alignment-independent 3D QSAR models 
3D QSAR models were made using Pentacle 1.06 software. [14] Pentacle calculates alignment-
independent descriptors (GRIND-2 descriptors) from molecular interaction fields (MIFs). [15] 
GRIND-2 descriptors are designed to overcome the major problem of 3D QSAR studies - 
structure alignment.  MIFs were calculated using four chemical probes: DRY, which represents 
hydrophobic interactions; O is sp2 carbonyl probe which mapped H-bond donor features of 
molecules; N1 is neutral flat –NH probing H-bond acceptors in molecules, and TIP probe which 
is introducing the shape of molecules in model building. Important positions around molecules 
(hot spots) are extracted from MIFs using AMANDA discretization algorithm. [16] Encoding of the 
filtered MIFs into GRIND variables was performed by the maximal auto- and cross-correlation 
(MACC2) algorithm. Obtained hot spots should represent 3D position of favorable interaction 
points of molecules, and should shape the virtual receptor site (VRS). All other parameters for 
MIF computation were as default. Since the number of calculated descriptors largely exceeds 
the number of compounds, matrix of descriptors is analyzed with principal component analysis 
(PCA) and partial least squares (PLS) regression analysis. [17] Initial conformation of compounds 
1-22 was generated in OMEGA 2.4.3, [18] using MMFF94s force field. [19] Database of lowest 
energy conformers was further optimized using semiempirical PM6 method implemented in 
MOPAC 2016. [20] VEGA ZZ 3.1.0 was used as a GUI. [21] 
 
 Figure S1.  1H NMR spectrum of 3 in DMSO-d6. 
 
Figure S2.13C NMR spectrum of 3 in DMSO-d6. 
 Figure S3.  1H NMR spectrum of 4 in DMSO-d6. 
 
 
Figure S4.13C NMR spectrum of 4 in DMSO-d6. 
 Figure S5.  1H NMR spectrum of 6 in DMSO-d6. 
 
Figure S6.13C NMR spectrum of 6 in DMSO-d6. 
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